Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 28, 2007; 13(48): 6562-6567
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6562
Serum pepsinogen levels and their influencing factors: A population-based study in 6990 Chinese from North China
Li-Ping Sun, Yue-Hua Gong, Lan Wang, Yuan Yuan
Li-Ping Sun, Yue-Hua Gong, Lan Wang, Yuan Yuan, Cancer Institute, First Affiliated Hospital, China Medical University, Shenyang 110001, Liaoning Province, China
Supported by National Key Technologies R&D Program of China during the 10th Five-year Plan Period, No. 2001BA703B06 (B), 2004BA703B04-02
Correspondence to: Dr. Yuan Yuan, Cancer Institute, First Affiliated Hospital, China Medical University, 155 Nanjing North Street, Shenyang 110001, Liaoning Province, China. yyuan@mail.cmu.edu.cn
Telephone: +86-24-83282153 Fax: +86-24-83282292
Received: June 11, 2007
Revised: October 9, 2007
Accepted: October 16, 2007
Published online: December 28, 2007
Abstract

AIM: To explore the essential characteristics of serum pepsinogen (PG) levels in Chinese people, by analyzing the population-based data on the serum levels of PGI and II and the PGI/II ratio, and their influencing factors in Chinese from North China.

METHODS: A total of 6990 subjects, who underwent a gastric cancer screening in North China from 1997 to 2002, were collected in this study. Serum pepsinogen levels were measured by enzyme-linked immunosorbent assay (ELISA). H pylori status was determined by histological examination and H pylori-IgG ELISA. The cut-off point was calculated by using receiving operator characteristics (ROC) curves. Factors linked to serum PGI/II ratio were identified using a multivariate logistic regression.

RESULTS: The serum PGI and PGII levels were significantly higher in males than in females (95.2 μg/L vs 79.7 μg/L, P < 0.01; 12.1 μg/L vs 9.4 μg/L, P < 0.01), PGI/II ratio was significantly lower in males than in females (7.9 vs 8.3, P < 0.01). The PGI/II ratio decreased significantly in the aged groups following the progression of gastric mucosa from normal to non-atrophic and atrophic lesions (10.4, 8.8, and 6.6, respectively). The serum PGIand II levels were significantly higher in patients with H pylori infection than in those without H pylori infection (88.7 μg/L vs 81.4 μg/L, P < 0.01; 11.4 μg/L vs 8.4 μg/L, P < 0.01), while the PGI/II ratio was significantly lower in patients with H pylori infection than in those without H pylori infection (7.7 vs 9.6, P < 0.01). For patients with atrophic lesions, the area under the PGI/II ROC curve was 0.622. The best cut-off point for PGI/II was 6.9, with a sensitivity of 53.2%, and a specificity of 67.5%. Factors linked to PGI/II were sensitive to identified PG using a multinomial logistic regression relying on the following inputs: males (OR: 1.151, 95% CI: 1.042-1.272, P = 0.006), age ≥ 61 years (OR: 1.358, 95% CI: 1.188-1.553, P = 0.000), atrophic lesion (OR: 2.075, 95% CI: 1.870-2.302, P = 0.000), and H pylori infection (OR: 1.546, 95% CI: 1.368-1.748, P = 0.000).

CONCLUSION: The essential characteristics of serum PG levels in Chinese are significantly skewed from the normal distribution, and influenced by age, sex, gastric mucosa lesions and H pylori infection. PGI/II ratio is more suitable for identifying subgroups with different influence factors compared with PGIor PGII alone.

Keywords: Pepsinogen, Gastric cancer, Helicobacter pylori, Screening